CVE-2020-12037
Last modified
CVE-2020-12037 is a high-severity vulnerability rated 7.5/10 on the CVSS scale. Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS (Patient Data Management System) or an EMR (Electronic Medical Record) system. An attacker could observe sensitive data sent from the device.. EPSS estimates a 0.48% chance of exploitation in the next 30 days.
Description
Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS (Patient Data Management System) or an EMR (Electronic Medical Record) system. An attacker could observe sensitive data sent from the device.
Metrics
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Baxter | Prismaflex Firmware | All versions |
| Baxter | Prismax Firmware | < 3.0 |
References
- https://www.us-cert.gov/ics/advisories/icsma-20-170-01Not Applicable
- https://us-cert.cisa.gov/ics/advisories/icsma-20-170-02Third Party Advisory
- https://www.us-cert.gov/ics/advisories/icsma-20-170-01Not Applicable
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2020-12037?
How severe is CVE-2020-12037?
How do I fix CVE-2020-12037?
Are you affected by CVE-2020-12037?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST
